Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy

Cancer Cell(2025)10.1016/j.ccell.2025.03.006Source: DataRank Database

Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0. It has been cited 52 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access52 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 25.51)OA: greenTopics (17)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Timothy A. Chan ORCID,Stephen L. Wang ORCID

Live enrichment

PubMed:40154483 PMC:PMC13171157 OpenAlex:https://openalex.org/W4408967782

National Institutes of Health National Cancer Institute

Grant: R35 CA232097

National Institutes of Health National Cancer Institute

Grant: R01 CA205426

National Institutes of Health National Cancer Institute

Grant: F30 CA294669

NIH National Institute of General Medical Sciences

Grant: T32 GM152319

NIH National Institute of General Medical Sciences

Grant: T32 GM007250

NCI NIH HHS

Grant: U54 CA274513

NCI NIH HHS

Grant: U01 CA260513

National Institutes of Health

California Community Foundation

FWCI

25.51

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13171157/

publisherhttps://api.elsevier.com/content/article/PII:S1535610825001072?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610825001072?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2025.03.006

Fields of Study

Cancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchLung Cancer Treatments and Mutations

MeSH Terms

Immune Checkpoint InhibitorsHumansNeoplasmsBiomarkers, TumorCTLA-4 AntigenProgrammed Cell Death 1 Receptor

Keywords

Immune checkpointImmune systemMedicineCancer researchImmunologyComputational biologyImmunotherapyBiology